1.Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study)
Grace S. AHN ; Kihwan HWANG ; Tae Min KIM ; Chul Kee PARK ; Jong Hee CHANG ; Tae-Young JUNG ; Jin Hee KIM ; Do-Hyun NAM ; Se-Hyuk KIM ; Heon YOO ; Yong-Kil HONG ; Eun-Young KIM ; Dong-Eun LEE ; Jungnam JOO ; Yu Jung KIM ; Gheeyoung CHOE ; Byung Se CHOI ; Seok-Gu KANG ; Jeong Hoon KIM ; Chae-Yong KIM
Cancer Research and Treatment 2022;54(2):396-405
Purpose:
The KNOG-1101 study showed improved 2-year PFS with temozolomide during and after radiotherapy compared to radiotherapy alone for patients with anaplastic gliomas. This trial investigates the effect of concurrent and adjuvant temozolomide on health-related quality of life (HRQoL).
Materials and Methods:
In this randomized, open-label, phase II trial, 90 patients with World Health Organization grade III glioma were enrolled across multiple centers in South Korea between March 2012 to February 2015 and followed up through 2017. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire 30 (EORTC QLQ-C30) and 20-item EORTC QLQ-Brain Neoplasm (QLQ-BN20) were used to compare HRQoL between patients assigned to concurrent chemoradiotherapy with temozolomide followed by 6 cycles of adjuvant temozolomide (arm A) and radiotherapy (RT) alone (arm B).
Results:
Of the 90 patients in the study, 84 patients (93.3%) completed the baseline HRQoL questionnaire. Emotional functioning, fatigue, nausea and vomiting, dyspnea, constipation, appetite loss, diarrhea, seizures, itchy skin, drowsiness, hair loss, and bladder control were not affected by the addition of temozolomide. All other items did not differ significantly between arm A and arm B throughout treatment. Global health status particularly stayed consistent at the end of adjuvant temozolomide (p=0.47) and at the end of RT (p=0.33).
Conclusion
The addition of concurrent and adjuvant temozolomide did not show negative influence on HRQoL with improvement of progression-free survival for patients with anaplastic gliomas. The absence of systematic and clinically relevant changes in HRQoL suggests that an overall long-term net clinical benefit exists for concurrent and adjuvant temozolomide.
2.Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade IIIGliomas without 1p/19q Co-deletion: A Randomized, Open-Label,Phase 2 Study (KNOG-1101 Study)
Kihwan HWANG ; Tae Min KIM ; Chul-Kee PARK ; Jong Hee CHANG ; Tae-Young JUNG ; Jin Hee KIM ; Do-Hyun NAM ; Se-Hyuk KIM ; Heon YOO ; Yong-Kil HONG ; Eun-Young KIM ; Dong-Eun LEE ; Jungnam JOO ; Yu Jung KIM ; Gheeyoung CHOE ; Byung Se CHOI ; Seok-Gu KANG ; Jeong Hoon KIM ; Chae-Yong KIM
Cancer Research and Treatment 2020;52(2):505-515
Purpose:
We investigated the efficacy of temozolomide during and after radiotherapy in Korean adultswith anaplastic gliomas without 1p/19q co-deletion.
Materials and Methods:
This was a randomized, open-label, phase 2 study and notably the first multicenter trial forKorean grade III glioma patients. Eligible patients were aged 18 years or older and hadnewly diagnosed non-co-deleted anaplastic glioma with an Eastern Cooperative OncologyGroup performance status of 0-2. Patients were randomized 1:1 to receive radiotherapyalone (60 Gy in 30 fractions of 2 Gy) (control group, n=44) or to receive radiotherapy withconcurrent temozolomide (75 mg/m2/day) followed by adjuvant temozolomide (150-200mg/m2/day for 5 days during six 28-day cycles) (treatment group, n=40). The primary endpointwas 2-year progression-free survival (PFS). Seventy patients (83.3%) were availablefor the analysis of the isocitrate dehydrogenase 1 gene (IDH1) mutation status.
Results:
The two-year PFS was 42.2% in the treatment group and 37.2% in the control group. Overallsurvival (OS) did not reach to significant difference between the groups. In multivariableanalysis, age was a significant risk factor for PFS (hazard ratio [HR], 2.08; 95% confidenceinterval [CI], 1.04 to 4.16). The IDH1mutation was the only significant prognostic factor forPFS (HR, 0.28; 95% CI, 0.13 to 0.59) and OS (HR, 0.19; 95% CI, 0.07 to 0.50). Adverseevents over grade 3 were seen in 16 patients (40.0%) in the treatment group and werereversible.
Conclusion
Concurrent and adjuvant temozolomide in Korean adults with newly diagnosed nonco-deleted anaplastic gliomas showed improved 2-year PFS. The survival benefit of this regimenneeds further analysis with long-term follow-up at least more than 10 years.
3.Isolation of Phytochemicals from Salvia plebeia Using Countercurrent Chromatography Coupled with Reversed-phase HPLC
Hyun Woo KIL ; Taewoong RHO ; Young Ju SEO ; Aram YU ; Kee Dong YOON
Natural Product Sciences 2020;26(3):236-243
Salvia plebeia R. Br. is a plant which has been used as an edible crop and traditional medicine in Asian countries. In this study, HPLC-PDA analysis and countercurrent chromatography (CCC) coupled with reversed-phase (RP) HPLC method were applied to isolate ten isolates from 3.3 g of n-butanol soluble extract from hot-water extract of S. plebeia. The use of CCC enabled us to efficiently fractionate the starting material with less sample loss and facilitate the isolation of compounds from S. plebeia extract using RP-HPLC. The isolates were determined to be caffeic acid (1), 6-hydroxyluteolin 7-O-β-D-glucoside (2), eudebeiolide B (3), (R)-rosmarinic acid (4), homoplantaginin (5), eudebeiolide D (6), plebeiolide C (7), salpleflavone (8), eupafolin (9) and hispidulin (10) based on the spectroscopic evidence.
4.Feedback Survey of the Effect, Burden, and Cost of the National Endoscopic Quality Assessment Program during the Past 5 Years in Korea.
Yu Kyung CHO ; Jeong Seop MOON ; Dong Su HAN ; Yong Chan LEE ; Yeol KIM ; Bo Young PARK ; Il Kwun CHUNG ; Jin Oh KIM ; Jong Pil IM ; Jae Myung CHA ; Hyun Gun KIM ; Sang Kil LEE ; Hang Lak LEE ; Jae Young JANG ; Eun Sun KIM ; Yunho JUNG ; Chang Mo MOON
Clinical Endoscopy 2016;49(6):542-547
BACKGROUND/AIMS: In Korea, the nationwide gastric cancer screening program recommends biennial screening for individuals aged 40 years or older by way of either an upper gastrointestinal series or endoscopy. The national endoscopic quality assessment (QA) program began recommending endoscopy in medical institutions in 2009. We aimed to assess the effect, burden, and cost of the QA program from the viewpoint of medical institutions. METHODS: We surveyed the staff of institutional endoscopic units via e-mail. RESULTS: Staff members from 67 institutions replied. Most doctors were endoscopic specialists. They responded as to whether the QA program raised awareness for endoscopic quality (93%) or improved endoscopic practice (40%). The percentages of responders who reported improvements in the diagnosis of gastric cancer, the qualifications of endoscopists, the quality of facilities and equipment, endoscopic procedure, and endoscopic reprocessing were 69%, 60%, 66%, 82%, and 75%, respectively. Regarding reprocessing, many staff members reported that they had bought new automated endoscopic preprocessors (3%), used more disinfectants (34%), washed endoscopes longer (28%), reduced the number of endoscopies performed to adhere to reprocessing guidelines (9%), and created their own quality education programs (59%). Many responders said they felt that QA was associated with some degree of burden (48%), especially financial burden caused by purchasing new equipment. Reasonable quality standards (45%) and incentives (38%) were considered important to the success of the QA program. CONCLUSIONS: Endoscopic quality has improved after 5 years of the mandatory endoscopic QA program.
Diagnosis
;
Disinfectants
;
Education
;
Electronic Mail
;
Endoscopes
;
Endoscopy
;
Korea*
;
Mass Screening
;
Motivation
;
Specialization
;
Stomach Neoplasms
5.The Interaction Between Prenatal Exposure to Home Renovation and Reactive Oxygen Species Genes in Cord Blood IgE Response is Modified by Maternal Atopy.
Jinho YU ; Kangmo AHN ; Youn Ho SHIN ; Kyung Won KIM ; Dong In SUH ; Ho Sung YU ; Mi Jin KANG ; Kyung Shin LEE ; Seo Ah HONG ; Kil Yong CHOI ; Eun LEE ; Song I YANG ; Ju Hee SEO ; Byoung Ju KIM ; Hyo Bin KIM ; So Yeon LEE ; Suk Joo CHOI ; Soo Young OH ; Ja Young KWON ; Kyung Ju LEE ; Hee Jin PARK ; Pil Ryang LEE ; Hye Sung WON ; Soo Jong HONG
Allergy, Asthma & Immunology Research 2016;8(1):41-48
PURPOSE: Although home renovation exposure during childhood has been identified as a risk factor for the development of allergy, there is limited information on the association between prenatal exposure to home renovation and cord blood (CB) IgE response. The aims of this study were to identify the effect of prenatal exposure to home renovation on CB IgE levels, and to investigate whether this exposure interacts with neonatal genes and whether the effect can be modified by maternal atopy. METHODS: This study included 1,002 mother-neonate pairs from the COhort for Childhood Origin of Asthma and allergic diseases (COCOA). Prenatal environmental factors were collected using a questionnaire. The levels of CB IgE were measured by the ImmunoCAP system, and DNA was extracted from CB. RESULTS: Exposure to home renovation during the prenatal period was associated with significantly higher levels of CB IgE only in neonates from atopic mothers, and the effect of renovation exposure on CB IgE levels persisted from 31 months before birth. Furthermore, prenatal exposure to home renovation increased the risk of CB IgE response interacting with polymorphisms of NRF2 and GSTP1 genes only in neonates from atopic mothers. CONCLUSIONS: Maternal atopy modified the effect of prenatal exposure to home renovation on CB serum IgE response as well as the interaction between the exposure and neonatal genes involved in the oxidative stress pathway. These findings suggest that the genetically susceptible offspring of atopic mothers may be more vulnerable to the effect of prenatal exposure to home renovation on the development of allergy.
Asthma
;
Cohort Studies
;
DNA
;
Fetal Blood*
;
Gene-Environment Interaction
;
Humans
;
Hypersensitivity
;
Immunoglobulin E*
;
Infant, Newborn
;
Mothers
;
Oxidative Stress
;
Parturition
;
Polymorphism, Single Nucleotide
;
Reactive Oxygen Species*
;
Risk Factors
6.Prenatal Particulate Matter/Tobacco Smoke Increases Infants' Respiratory Infections: COCOA Study.
Song I YANG ; Byoung Ju KIM ; So Yeon LEE ; Hyo Bin KIM ; Cheol Min LEE ; Jinho YU ; Mi Jin KANG ; Ho Sung YU ; Eun LEE ; Young Ho JUNG ; Hyung Young KIM ; Ju Hee SEO ; Ji Won KWON ; Dae Jin SONG ; Gwangcheon JANG ; Woo Kyung KIM ; Jung Yeon SHIM ; Soo Young LEE ; Hyeon Jong YANG ; Dong In SUH ; Seo Ah HONG ; Kil Yong CHOI ; Youn Ho SHIN ; Kangmo AHN ; Kyung Won KIM ; Eun Jin KIM ; Soo Jong HONG
Allergy, Asthma & Immunology Research 2015;7(6):573-582
PURPOSE: To investigate whether prenatal exposure to indoor fine particulate matter (PM2.5) and environmental tobacco smoke (ETS) affects susceptibility to respiratory tract infections (RTIs) in infancy, to compare their effects between prenatal and postnatal exposure, and to determine whether genetic factors modify these environmental effects. METHODS: The study population consisted of 307 birth cohort infants. A diagnosis of RTIs was based on parental report of a physician's diagnosis. Indoor PM2.5 and ETS levels were measured during pregnancy and infancy. TaqMan was used for genotyping of nuclear factor erythroid 2-related factor (Nrf2) (rs6726395), glutathione-S-transferase-pi (GSTP) 1 (rs1695), and glutathione-S-transferase-mu (GSTM) 1. Microarrays were used for genome-wide methylation analysis. RESULTS: Prenatal exposure to indoor PM2.5 increased the susceptibility of lower RTIs (LRTIs) in infancy (adjusted odds ratio [aOR]=2.11). In terms of combined exposure to both indoor PM2.5 and ETS, prenatal exposure to both pollutants increased susceptibility to LRTIs (aOR=6.56); however, this association was not found for postnatal exposure. The Nrf2 GG (aOR=23.69), GSTM1 null (aOR=8.18), and GSTP1 AG or GG (aOR=7.37) genotypes increased the combined LRTIs-promoting effects of prenatal exposure to the 2 indoor pollutants. Such effects of prenatal indoor PM2.5 and ETS exposure were not found for upper RTIs. CONCLUSIONS: Prenatal exposure to both indoor PM2.5 and ETS may increase susceptibility to LRTIs. This effect can be modified by polymorphisms in reactive oxygen species-related genes.
Cacao*
;
Cohort Studies
;
Diagnosis
;
Genotype
;
Humans
;
Infant
;
Methylation
;
Odds Ratio
;
Oxygen
;
Parents
;
Particulate Matter
;
Parturition
;
Pregnancy
;
Respiratory Tract Infections*
;
Smoke*
;
Tobacco
7.Prenatally Diagnosed Dural Sinus Thrombosis.
In Kook JUNG ; Yu Li SOL ; Jong Kil JOO ; Dong Hyung LEE ; Seung Chul KIM
Korean Journal of Perinatology 2011;22(4):350-355
Thrombosis of the dural sinus in the fetal period is an extremely rare congenital cerebrovascular condition. The exact etiologies and prognosis of dural sinus thrombosis in the fetal period are still unknown due to the extremely limited clinical information available. Therefore, we present a case of dural sinus thrombosis diagnosed by prenatal ultrasound and fetal magnetic resonance imaging that spontaneously regressed, with a brief review of the relevant literature.
Magnetic Resonance Imaging
;
Prenatal Diagnosis
;
Prognosis
;
Sinus Thrombosis, Intracranial
;
Thrombosis
8.Radiation-induced brain injury: retrospective analysis of twelve pathologically proven cases.
Dong Soo LEE ; Mina YU ; Hong Seok JANG ; Yeon Sil KIM ; Byung Ock CHOI ; Young Nam KANG ; Youn Soo LEE ; Dong Chul KIM ; Yong Kil HONG ; Sin Soo JEUN ; Sei Chul YOON
Radiation Oncology Journal 2011;29(3):147-155
PURPOSE: This study was designed to determine the influencing factors and clinical course of pathologically proven cases of radiation-induced brain injury (RIBI). MATERIALS AND METHODS: The pathologic records of twelve patients were reviewed; these patients underwent surgery following radiotherapy due to disease progression found by follow-up imaging. However, they were finally diagnosed with RIBI. All patients had been treated with 3-dimensional conventional fractionated radiotherapy and/or radiosurgery for primary or metastatic brain tumors with or without chemotherapy. The histological distribution was as follows: two falx meningioma, six glioblastoma multiform (GBM), two anaplastic oligodendroglioma, one low grade oligodendroglioma, and one small cell lung cancer with brain metastasis. RESULTS: Radiation necrosis was noted in eight patients and the remaining four were diagnosed with radiation change. Gender (p = 0.061) and biologically equivalent dose (BED)3 (p = 0.084) were the only marginally influencing factors of radiation necrosis. Median time to RIBI was 7.3 months (range, 0.5 to 61 months). Three prolonged survivors with GBM were observed. In the subgroup analysis of high grade gliomas, RIBI that developed <6 months after radiotherapy was associated with inferior overall survival rates compared to cases of RIBI that occurred > or =6 months (p = 0.085). CONCLUSION: Our study demonstrated that RIBI could occur in early periods after conventional fractionated brain radiotherapy within normal tolerable dose ranges. Studies with a larger number of patients are required to identify the strong influencing factors for RIBI development.
Brain
;
Brain Injuries
;
Brain Neoplasms
;
Disease Progression
;
Follow-Up Studies
;
Glioblastoma
;
Glioma
;
Humans
;
Meningioma
;
Necrosis
;
Oligodendroglioma
;
Radiation Injuries
;
Radiosurgery
;
Retrospective Studies
;
Small Cell Lung Carcinoma
;
Survival Rate
;
Survivors
9.Abnormal Blood Flow Between a Pericardial Mass and Right Atrium Detected by Echocardiography in a Case of a Ruptured Angiosarcoma of the Right Atrium.
Mi Seung SHIN ; Woong Chol KANG ; Young Saeng KIM ; Eun Ju YU ; Kyu Hyun YOON ; Kil Hyun KIM ; Wook Jin CHUNG ; Dong Hae JUNG ; Chul Hyun PARK ; Eak Kyun SHIN
Journal of Cardiovascular Ultrasound 2007;15(3):82-85
Spontaneous rupture of a primary cardiac angiosarcoma is a rare condition with a poor prognosis. The authors describe the case of a 48-year-old man with abnormal blood flow from a pericardial mass to the right atrium 3 months after pericardiocentesis. The flow was presumed to have occurred due to rupture of this cardiac angiosarcoma of the right atrial wall and pericardium into the right atrial cavity.
Echocardiography*
;
Heart Atria*
;
Hemangiosarcoma*
;
Humans
;
Middle Aged
;
Pericardiocentesis
;
Pericardium
;
Prognosis
;
Rupture
;
Rupture, Spontaneous
10.Abnormal Blood Flow Between a Pericardial Mass and Right Atrium Detected by Echocardiography in a Case of a Ruptured Angiosarcoma of the Right Atrium.
Mi Seung SHIN ; Woong Chol KANG ; Young Saeng KIM ; Eun Ju YU ; Kyu Hyun YOON ; Kil Hyun KIM ; Wook Jin CHUNG ; Dong Hae JUNG ; Chul Hyun PARK ; Eak Kyun SHIN
Journal of Cardiovascular Ultrasound 2007;15(3):82-85
Spontaneous rupture of a primary cardiac angiosarcoma is a rare condition with a poor prognosis. The authors describe the case of a 48-year-old man with abnormal blood flow from a pericardial mass to the right atrium 3 months after pericardiocentesis. The flow was presumed to have occurred due to rupture of this cardiac angiosarcoma of the right atrial wall and pericardium into the right atrial cavity.
Echocardiography*
;
Heart Atria*
;
Hemangiosarcoma*
;
Humans
;
Middle Aged
;
Pericardiocentesis
;
Pericardium
;
Prognosis
;
Rupture
;
Rupture, Spontaneous

Result Analysis
Print
Save
E-mail